Which of the following is NOT typically part of direct costs in drug therapy?

Transportation costs are not typically considered a direct cost of drug therapy. Direct costs generally refer to expenses that are directly associated with the treatment provided, including the cost of the medication itself, any follow-up care required for monitoring or managing treatment outcomes, and costs directly related to managing side effects or other therapy-related issues, such as pain management.

In the context of healthcare, direct costs encompass the cost of treatments received directly by the patient. This includes medications, lab tests, and procedural expenses. While pain management and follow-up care are part of the treatment process and therefore contribute directly to the therapeutic regimen, transportation costs are considered indirect costs. They pertain to the costs incurred by patients to access those treatments, which may include travel to the pharmacy or clinic, rather than costs that are directly associated with the drug therapy itself. Evaluating costs in this manner helps healthcare providers and policymakers understand the financial implications of treatment options and assess the overall healthcare burden more comprehensively.